Skip to main content

Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419

Head and Neck Cancer, Audiocast
Audiocasts

Carryn Anderson, MD, discusses the clinical significance of her research on, “Severe Oral Mucositis Less Frequent, Briefer, Less Severe with Use of GC4419.”

Get TOP in Your Inbox

Stay up to date with the latest oncology pharmacy news and insights by subscribing to our e-newsletter!

SUBSCRIBE

Related Items

New Saliva Test Accurately Detects HPV-Associated Head and Neck Cancer
By William King
TOP - November 2021 Vol 14, No 7
Head and Neck Cancer
November 4, 2019 — Oncology News & Updates
Web Exclusives
Financial Toxicity, Head and Neck Cancer, Hematologic Cancers, In the News, Leukemia
Oral Cancer and Sex in the Era of HPV Infection
By Meg Barbor, MPH
Web Exclusives
Head and Neck Cancer
Low Survival in Patients with Head and Neck Cancers Linked to Delays in Radiation Therapy After Surgery
By Corbin Davis
TOP - August 2018, Vol 11, No 2
Head and Neck Cancer